Incorporated in 1986, MIC Electronics is a Hyderabad based company whose business revolves mainly around LED (light emitting diode) and LED based products. The company broadly has two segments media, and informatics and communications (ICT). The form... More
Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More
MIC ELECTRONICS | INDOCO REMEDIES | MIC ELECTRONICS/ INDOCO REMEDIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -0.3 | 76.2 | - | View Chart |
P/BV | x | - | 4.4 | - | View Chart |
Dividend Yield | % | 0.0 | 0.3 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
MIC ELECTRONICS Mar-18 |
INDOCO REMEDIES Mar-18 |
MIC ELECTRONICS/ INDOCO REMEDIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 16 | 317 | 5.0% | |
Low | Rs | 4 | 178 | 2.5% | |
Sales per share (Unadj.) | Rs | 7.5 | 113.1 | 6.6% | |
Earnings per share (Unadj.) | Rs | -8.7 | 4.5 | -194.5% | |
Cash flow per share (Unadj.) | Rs | -8.3 | 11.8 | -70.6% | |
Dividends per share (Unadj.) | Rs | 0 | 1.00 | 0.0% | |
Dividend yield (eoy) | % | 0 | 0.4 | 0.0% | |
Book value per share (Unadj.) | Rs | -3.5 | 73.2 | -4.8% | |
Shares outstanding (eoy) | m | 220.25 | 92.15 | 239.0% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 1.4 | 2.2 | 62.5% | |
Avg P/E ratio | x | -1.2 | 55.5 | -2.1% | |
P/CF ratio (eoy) | x | -1.2 | 21.0 | -5.8% | |
Price / Book Value ratio | x | -2.9 | 3.4 | -85.9% | |
Dividend payout | % | 0 | 22.4 | 0.0% | |
Avg Mkt Cap | Rs m | 2,247 | 22,830 | 9.8% | |
No. of employees | `000 | 0.2 | 5.5 | 2.9% | |
Total wages/salary | Rs m | 57 | 2,209 | 2.6% | |
Avg. sales/employee | Rs Th | 10,456.7 | 1,910.1 | 547.5% | |
Avg. wages/employee | Rs Th | 359.9 | 405.0 | 88.9% | |
Avg. net profit/employee | Rs Th | -12,188.5 | 75.5 | -16,153.7% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,642 | 10,419 | 15.8% | |
Other income | Rs m | 12 | 47 | 24.9% | |
Total revenues | Rs m | 1,653 | 10,466 | 15.8% | |
Gross profit | Rs m | -2,202 | 1,349 | -163.2% | |
Depreciation | Rs m | 78 | 677 | 11.4% | |
Interest | Rs m | 244 | 235 | 103.9% | |
Profit before tax | Rs m | -2,512 | 484 | -519.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | -599 | 72 | -826.7% | |
Profit after tax | Rs m | -1,914 | 412 | -464.9% | |
Gross profit margin | % | -134.1 | 12.9 | -1,035.8% | |
Effective tax rate | % | 23.8 | 15.0 | 159.3% | |
Net profit margin | % | -116.6 | 4.0 | -2,950.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 899 | 5,373 | 16.7% | |
Current liabilities | Rs m | 2,754 | 4,157 | 66.2% | |
Net working cap to sales | % | -113.0 | 11.7 | -968.0% | |
Current ratio | x | 0.3 | 1.3 | 25.3% | |
Inventory Days | Days | 112 | 68 | 165.9% | |
Debtors Days | Days | 75 | 73 | 103.1% | |
Net fixed assets | Rs m | 916 | 6,244 | 14.7% | |
Share capital | Rs m | 441 | 184 | 239.0% | |
"Free" reserves | Rs m | -1,214 | 6,566 | -18.5% | |
Net worth | Rs m | -774 | 6,750 | -11.5% | |
Long term debt | Rs m | 0 | 1,233 | 0.0% | |
Total assets | Rs m | 2,002 | 12,363 | 16.2% | |
Interest coverage | x | -9.3 | 3.1 | -303.6% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 0.8 | 0.8 | 97.3% | |
Return on assets | % | -83.4 | 5.2 | -1,594.0% | |
Return on equity | % | 247.4 | 6.1 | 4,057.0% | |
Return on capital | % | 293.2 | 9.0 | 3,254.8% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 1.3 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 22 | NA | - | |
Fx inflow | Rs m | 0 | 3,762 | 0.0% | |
Fx outflow | Rs m | 23 | 1,143 | 2.0% | |
Net fx | Rs m | -23 | 2,619 | -0.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 329 | 1,227 | 26.8% | |
From Investments | Rs m | -1 | -1,360 | 0.0% | |
From Financial Activity | Rs m | -330 | -388 | 85.0% | |
Net Cashflow | Rs m | -1 | -521 | 0.2% |
Indian Promoters | % | 8.0 | 59.2 | 13.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 12.5 | - | |
FIIs | % | 0.0 | 6.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 91.2 | 22.4 | 407.1% | |
Shareholders | 43,926 | 12,805 | 343.0% | ||
Pledged promoter(s) holding | % | 54.4 | 0.0 | - |
Compare MIC ELECTRONICS With: WONDERLA HOLIDAYS TIMKEN INDIA RELIGARE ENT BAJAJ FINANCE JSW HOLDINGS
Indian share markets ended on a positive note yesterday. At the closing bell yesterday, the BSE Sensex stood higher by 375 points (up 0.8%).
Key takeaways from Bajaj Consumer Care's March quarter results.
Key takeaways from Nestle's March quarter (Q1CY21) results.
For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.
For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.
For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
In this video I tell you the three Nifty ETFs I think are the best.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
There is no stopping this 11-bagger stock from significant upside.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
More